Literature DB >> 14555857

Interleukin-10 influences the expression of MRP8 and MRP14 in human dendritic cells.

Anita Kumar1, Alexander Steinkasserer, Susanne Berchtold.   

Abstract

BACKGROUND: We investigated the differential gene expression of human dendritic cells (DC) under the influence of the cytokine interleukin-10 (IL-10).
METHODS: The gene expression profiles of IL-10-treated DC and untreated DC (untreated control) were compared using cDNA expression array.
RESULTS: In this array, several differentially expressed transcripts could be identified. Two of them, the transcripts for the myeloid-related proteins (MRPs) MRP8 and MRP14, were examined more closely. The transcripts encoding for these proteins were expressed in mature untreated DC, and significantly induced in IL-10-treated DC.
CONCLUSIONS: These data demonstrate that the genes for MRP8 and MRP14 are expressed in various DC subpopulations in different intensity, depending on their maturational status and are increased after the treatment with IL-10. Expression of the genes for MRP8 and MRP14 in DC has not been reported before. These results point to different, still unknown functions of these two proteins in DC: to a role in DC maturation, and possibly to an influence on the creation of tolerogenic T cells under the influence of IL-10. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14555857     DOI: 10.1159/000073263

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  9 in total

1.  Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.

Authors:  Koichi Shimizu; Peter Libby; Viviane Z Rocha; Eduardo J Folco; Rica Shubiki; Nir Grabie; Sunyoung Jang; Andrew H Lichtman; Ayako Shimizu; Nancy Hogg; Daniel I Simon; Richard N Mitchell; Kevin Croce
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

2.  ANTI-INFECTIVE PROTECTIVE PROPERTIES OF S100 CALGRANULINS.

Authors:  Kenneth Hsu; Chantrakorn Champaiboon; Brian D Guenther; Brent S Sorenson; Ali Khammanivong; Karen F Ross; Carolyn L Geczy; Mark C Herzberg
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-12-04

3.  Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.

Authors:  A Deguchi; T Tomita; U Ohto; K Takemura; A Kitao; S Akashi-Takamura; K Miyake; Y Maru
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

4.  S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells: implications for atherosclerosis and adipose tissue inflammation.

Authors:  Michelle M Averill; Shelley Barnhart; Lev Becker; Xin Li; Jay W Heinecke; Renee C Leboeuf; Jessica A Hamerman; Clemens Sorg; Claus Kerkhoff; Karin E Bornfeldt
Journal:  Circulation       Date:  2011-03-07       Impact factor: 29.690

Review 5.  S100A8 and S100A9 in cardiovascular biology and disease.

Authors:  Michelle M Averill; Claus Kerkhoff; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-17       Impact factor: 8.311

6.  IL-10 induces an immune repressor pathway in sepsis by promoting S100A9 nuclear localization and MDSC development.

Authors:  Isatou Bah; Ajinkya Kumbhare; Lam Nguyen; Charles E McCall; Mohamed El Gazzar
Journal:  Cell Immunol       Date:  2018-07-11       Impact factor: 4.868

7.  Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein.

Authors:  Pingyan Cheng; Cesar A Corzo; Noreen Luetteke; Bin Yu; Srinivas Nagaraj; Marylin M Bui; Myrna Ortiz; Wolfgang Nacken; Clemens Sorg; Thomas Vogl; Johannes Roth; Dmitry I Gabrilovich
Journal:  J Exp Med       Date:  2008-09-22       Impact factor: 14.307

8.  Targeting S100A9 Reduces Neutrophil Recruitment, Inflammation and Lung Damage in Abdominal Sepsis.

Authors:  Zhiyi Ding; Feifei Du; Richard Garland Averitt V; Gabriel Jakobsson; Carl-Fredrik Rönnow; Milladur Rahman; Alexandru Schiopu; Henrik Thorlacius
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 6.208

Review 9.  Calprotectin: from biomarker to biological function.

Authors:  Almina Jukic; Latifa Bakiri; Erwin F Wagner; Herbert Tilg; Timon E Adolph
Journal:  Gut       Date:  2021-06-18       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.